Novadel Pharma Inc. (NVD) Posts Q3 Loss of 2c, In-Line with Views
Novadel Pharma Inc. (AMEX: NVD) reports Q3 loss of $0.02, even wtih the analyst estimate of ($0.02). Revenue for the quarter was $223,000, which compares to the estimate of $70,000.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Mentor Graphics Corp (MENT) Beats Q1 EPS View by 5c; Lifts FY13 Outlook
- Jiayuan.com (DATE) Reports In-Line Q1 EPS of 5c; Guides Q2 Revs
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
